Following some great feedback and new business as a result of the talks we’ve given at the last 3 annual meetings (read my review of the 2014 event here, check out the slides from my ‘Smartphones: a clinical trial platform’ talk in 2015 and view the video and slides from my talk last year on what would happen if we took a Mobile First approach to designing Clinical Trials) we’ve been invited back to present on the topic of “Using emerging technologies to drive patient centricity into clinical trials” at the 2017 Clinical Innovation and Partnering World which will be held at the Hilton Tower Bridge Hotel in London.
“Clinical Innovation and Partnering World is one of the most established and valuable conferences for the pharmaceutical and biotech community. Over recent years, there has been more and more discussion about the challenges facing pharma and the resulting need for innovation and change in clinical trials. We listened, and have created an event that breaks down the silos of clinical trial development. Clinical Innovation and Partnering World brings together leading experts in the fields of Clinical Innovation, Outsourcing, Alliance management and Strategic partnering to offer different perspectives on the same challenges.
Building on the successful 2016 event, we’ve kept the individual tracks so attendees can cherry pick the sessions of most interest to them. Collaboration, partnering, advancing technology, innovation and sharing experience are essential for industry to progress – this unmissable event covers all of this and more. We put the focus on disruptors in clinical outsourcing and innovation. We have fresh interactive formats and our speakers are genuine senior innovators and proactive thought leaders. Bringing together big pharma, SME biotechs, CROs, technology firms and partners, we will discuss developments and practical solutions to challenges in clinical research. Join us in London this March as we celebrate our 10th successful annual show and help shape the future of the clinical research, outsourcing and partnering strategies”
Keynote Topics include:
Transforming clinical trials to meet demands of the future
‘putting patients at the heart of research’
Smart Technologies Transforming Patient Engagement: from Concept to Reality!
Engaging the patient by providing data access and inclusion in a trial community
The Good, The Bad, The Ugly of the Sponsor – CRO relationship
Delivering patient centred science
Developing a successful outsourcing strategy
How to drive patient centric trials by partnering with a patient advocacy group
Disruptive procurement methods: Choosing your CRO
The UK Accelerated Access Review – a summary of recommendations, how patients can be involved and add to the process of innovation.
Patients as partners – transforming the delivery of clinical research in the NHS
Understanding how to partner with charities to deliver patient centric clinical trials
Understanding how your RBM strategy fits into your overall quality management system
Disrupting clinical trials: looking at the bigger picture:
Risk based monitoring: What could go wrong in my trial, from a data point of view?
Using emerging technologies to drive patient centricity into clinical trials
Overcoming the challenges in implementing new technologies for clinical research
Fair market value and safety notification portals:
OpenTrials: an open, easy-to-use, linked database of information about the world’s clinical trials
Engaging and Involving patients in the Charity Sector
Clinical data sharing and ethics
How to embrace disruption in your clinical development program
THE ACCELERATOR- Showcasing clinical innovations of the future: featuring Epilepsy Self Monitor, ERAS+, DrDoctor, MyCOPD, Owise, AliveCor, Health Unlocked, Sleepio and Patients Know Best.
Confirmed Speakers include:
Nadir Ammour, Head Patient’s, Partner, Technology and Information Management, Sanofi
Tamzin Blagbrough, European Sourcing Consultant, Eli Lilly And Co
Dr Ed Cartwright, CEO/Founder, Cloud of Experts
Tim Cave, VP, Medical Affairs Strategic Planning & Digital Practices, Global Medical Platforms and Capabilities (GMPC), R&D Chief MedicalOffice, GSK
Joana Claverol, Clinical Research Unit Manager, Sant Joan de Deu Barcelona Children’s Hospital , Research Foundation
Matt Cooper, Director of Business Development and Marketing, NIHR
Eileen Dergarabedian, Cluster Clinical Operations Head, Novartis
David Doherty, Co-Founder, 3G Doctor
Caroline Feys, R&D Operations Innovation Leader, Janssen Pharmaceutical Companies of Johnson & Johnson
Olena Goloborodko, Associate Director, Portfolio Sourcing and Relationship Management, Celgene
Bert Hartog, Director R&D Operations – Innovation Leader, Johnson and Johnson
Iain Hennessey, Clinical Director of Innovation, Consultant Paediatric Surgeon, Alder Hey Children’s Hospital
Lucy Herbert-Pike, Director of External Supply, Shire
Adama Ibrahim, Senior Clinical Operations Lead at Biogen and Women in Innovation UK Chapter Co-Lead, Biogen Idec
Lukasz Kniola, Principal Analyst Data Sharing, Biogen
Jim Kremidas, Executive Director, Association Of Clinical Research Professionals
Robert Kroes, Project Lead Clinical Open Innovation Europe, Lilly Nederland BV
Muna Kugler, Associate Director Global Outsourcing Clinical Trials, Group Leader, Actelion Eric Low, Chief Executive Officer, Myeloma U.K.
Dr Yuri Martina, Vice Pres ident Clinical Operations, Shionogi Ltd
Amal Masalmeh, Senior Clinical Research Associate, Novartis
Ben Meghreblian, OpenTrials Community Manager, Open Trials
Paulo Moreira, VP, GCO – External Innovation, EMD Merck Serono
Eibhlin Mulroe, CEO, Cancer Trials Ireland (formerly ICORG)
Stephen Nabarro, Head of Clinical Operations and Data Management, Centre for Drug Development, Cancer Research UK
Hilary Newiss, Chair, National Voices
Johann Proeve, Clinical Data Management Consultant, Ex-Head Global Data Management Bayer
Jane Rhodes, Senior Director, New Initiatives, Innovation Hub, Biogen
Magdalena Schoeneich, Head of Takeda Digital Accelerator, R&D, Takeda Pharmaceuticals Dr Suvodip Shaw, Central Monitoring Operations Manager- Global Central Monitoring RBM, Novartis
Jonathan Sheffield, Chief Executive Officer, National Institute For Health Research
Olesia Sledge, Head of Global Clinical Trial Management, Novartis
Marc Sluijs, Digital health investment advisory, Merck
Rene Stephens, Executive Director and Global Head of Global Contracts and Outsourcing Management, Astellas Pharma
Derek Stewart, OBE, Chair & Associate Director for Patient & Public Involvement, NIHR Clinical Research Network
Guy Yeoman, VP Patient Centricity, Global Medical Affairs, AstraZeneca
Michael Zorer, Head of Clinical Operations, A.O.P. Orphan Pharmaceuticals Ag
Want to get involved in the Clinical Innovation Congress?
NOTE: Refresh this page on the 9th March 2017 to see the video of and the slides that accompanied our presentation.